GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (OTCPK:AMEUF) » Definitions » PB Ratio
中文

Anteris Technologies (Anteris Technologies) PB Ratio : 13.69 (As of Apr. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Anteris Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-24), Anteris Technologies's share price is $14.70. Anteris Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was $1.07. Hence, Anteris Technologies's PB Ratio of today is 13.69.

The historical rank and industry rank for Anteris Technologies's PB Ratio or its related term are showing as below:

AMEUF' s PB Ratio Range Over the Past 10 Years
Min: 0.95   Med: 4.69   Max: 34.88
Current: 13.61

During the past 13 years, Anteris Technologies's highest PB Ratio was 34.88. The lowest was 0.95. And the median was 4.69.

AMEUF's PB Ratio is ranked worse than
95.85% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 2.21 vs AMEUF: 13.61

During the past 12 months, Anteris Technologies's average Book Value Per Share Growth Rate was 68.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 60.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Anteris Technologies was 60.70% per year. The lowest was -43.30% per year. And the median was -21.80% per year.

Back to Basics: PB Ratio


Anteris Technologies PB Ratio Historical Data

The historical data trend for Anteris Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies PB Ratio Chart

Anteris Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.98 9.95 10.26 23.99 12.29

Anteris Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.26 12.48 23.99 15.28 12.29

Competitive Comparison of Anteris Technologies's PB Ratio

For the Medical Devices subindustry, Anteris Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's PB Ratio falls into.



Anteris Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Anteris Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=14.70/1.074
=13.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Anteris Technologies  (OTCPK:AMEUF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Anteris Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies (Anteris Technologies) Business Description

Traded in Other Exchanges
Address
Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.